UOC
DCGOW

UBS O'Connor’s DocGo Inc. Warrants DCGOW Stock Holding History

UBS O'Connor’s Portfolio DCGOW Stock Details DCGOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-166,660
Closed -$215K – 1099
2021
Q3 		$215K Hold
166,660
– – ﹤0.01% 707
2021
Q2 		$243K Hold
166,660
– – ﹤0.01% 692
2021
Q1 		$177K Buy
+166,660
New +$258K ﹤0.01% 692

Other funds holding DCGOW

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
ICMH
Integrity Capital Management (HK) Central, Hong Kong $64K AUM
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

UBS O'Connor's DCGOW Position: Q4 2021 in Review

UBS O'Connor sold out of DocGo Inc. Warrants (DCGOW) in Q4 2021, closing a stake of 166,660 shares — an estimated $215K sold.

UBS O'Connor first reported a position in DCGOW in Q1 2021 and held it in 3 quarters. The position peaked at $243K in Q2 2021. 13 funds tracked by Wall St. Rank hold DCGOW as of Q4 2021.

  • UBS O'Connor reported no remaining DocGo Inc. Warrants position as of Q4 2021 after selling out during the quarter.
  • UBS O'Connor sold 166,660 DocGo Inc. Warrants shares in Q4 2021, an estimated $215K.
  • UBS O'Connor first reported a position in DocGo Inc. Warrants in Q1 2021 and held it in 3 quarters.
  • UBS O'Connor's DocGo Inc. Warrants position peaked at $243K in Q2 2021.
  • 13 funds tracked by Wall St. Rank held DocGo Inc. Warrants as of Q4 2021.

Based on UBS O'Connor's 13F filing for Q4 2021, filed 14 Feb 2022.